MARKETING RESEARCH OF PHARMACEUTICAL MARKET OF MEDICINES FOR TREATMENT OF CARDIOVASCULAR DISEASES

Authors

  • A. S. Nemchenko National University of Pharmacy
  • Yu. Ye. Kurylenko National University of Pharmacy

DOI:

https://doi.org/10.11603/2312-0967.2018.2.9086

Keywords:

cardiovascular diseases, pharmaceutical market, accessibility of medicines.

Abstract

The aim of the work. Carrying out marketing research of the pharmaceutical market (FM) of medicines recommended for the treatment of cardiovascular diseases (CVD).

Materials and Methods. The study used the drugs that were included in the unified clinical protocol for the treatment of CVD under the international non-proprietary name (INN) and the registration of drug names under the trade names (TN). Methods of marketing analysis, analytical, comparative and generalization of information are used.

Results and Discussion. The results of a marketing study of the drug for treatment of CVD for 2013–2017 are presented. The average values of the drug price index, the liquidity of the price and the availability of МD, which are used in pharmacotherapy, are calculated CVD.

Conclusions. It has been established that a significant prevalence of preparations of foreign manufacture on FM over domestic 70.05 % to 29.95 %. The increase in prices for preparations of foreign manufacturers was 1.09 times and for domestic ones 1.06 times, used to treat CVD in2017 in comparison with 2013 for influenced the decrease in the availability of this category of MD for the population. In connection with this, the need for the development of domestic production and the introduction of import substitution programs, as well as the development of government programs for state regulation of prices, in particular, reference pricing, is acquiring ever greater socio-economic importance.

Author Biographies

A. S. Nemchenko, National University of Pharmacy

Doctor of Pharmacy (Dr. habil.), head of the Organization and Economy of Pharmacy Department, National University of Pharmacy

Yu. Ye. Kurylenko, National University of Pharmacy

PhD student of the Organization and Economy of Pharmacy Department, National University of Pharmacy

References

World Health Organization. [Electronic resource, Geneva]. Available from:http://www.who.int/en/[Accessed October 2017].

Nemchenko AS, Kurylenko YuYe. [Analysis of the availability of essential medicines for the treatment of heart failure in the domestic pharmaceutical market]. Actual problems of development of branch economy and logistics: materials V Sciences-practice. conf. from international participation. Kharkiv; 2017. p. 410-1. Ukrainian.

Kotvytskaia AA, Krasulia OY. [Marketing analysis of the market of drugs that are used to treat myocardial infarction]. Nauch. vedomosti Belgorodskoho gos. universiteta. 2013;7(147):208-13. Russian.

Slobodianiuk MM, Baihush YuV. [Marketing analysis of the cardiovascular market in Ukraine]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. 2016;1:72-9. Ukrainian.

Yakovlieva LV, Portianka MM, Kyrychenko OM. [An analysis of the availability of drugs for the treatment of hypertension]. Social Pharmacy: Status, Problems and Prospects: Materials of Sciences. symposium within the VIII National the Congress of Pharmacists of Ukraine. Kharkiv: 2016;141. Ukrainian.

Townsend N, Wilson L. Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal. 2016;37(42):3232-45.

Ortegon MM. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ. 2012.

Wirtz VJ. Access to medications for cardiovascular diseases in low- and middle-income countries. Circulation. 2016;133(21):2076-85.

Pro zatverdzhennia protokoliv nadannia medychnoi dopomohy za spetsialnistiu “Kardiolohiia”. [Electronic resource, Ukrainian]. Available from: https://medprosvita.com.ua/nakaz-vid-03-07-2006-n-436-pro-zatverdzhennya-proto/ [Accessed October 2017]. Ukrainian.

Derzhavnyi reiestr likarskykh zasobiv Ukrainy [Electronic resource, Ukrainian]. Available from:http://www.drlz.com.ua/[Accessed December 2017]. Ukrainian.

Nemchenko AS, Kosiachenko KL, Nemchenko OA. Pricing for drugs: a monograph. [Ціноутворення на лікарські засоби: моно- графія] Kharkiv: Vy-vo FOP Vyrovets AP Vydavnycha hrupa “Apostrof”; 2012. Ukrainian.

Downloads

Published

2018-06-21

How to Cite

Nemchenko, A. S., & Kurylenko, Y. Y. (2018). MARKETING RESEARCH OF PHARMACEUTICAL MARKET OF MEDICINES FOR TREATMENT OF CARDIOVASCULAR DISEASES. Pharmaceutical Review Farmacevtičnij časopis, (2), 77–81. https://doi.org/10.11603/2312-0967.2018.2.9086

Issue

No. 2 (2018)

Section

Pharmaceutical management, marketing and logistics

License

The authors who publish their materials in this journal agree with the following terms:

  • Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal Результат пошуку зображень за запитом "CC-BY logo".
  • Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.

Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).